moxifloxacin has been researched along with Multiple Organ Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Su, LX; Xiao, YJ; Xie, LX; Zhang, X | 1 |
| Deng, H; Li, J; Li, Q; Wen, R | 1 |
| Bach, F; Bloos, F; Bogatsch, H; Brunkhorst, FM; Büchler, MW; Engel, C; Fritz, H; Gründling, M; Jaschinski, U; John, S; Kiehntopf, M; Kollef, MH; Kuhnt, E; Loeffler, M; Ludewig, K; Marx, G; Meier-Hellmann, A; Moerer, O; Nierhaus, A; Oppert, M; Putensen, C; Ragaller, M; Reill, L; Reinhart, K; Riessen, R; Seibel, A; Spies, C; Welte, T; Weyland, A | 1 |
| Kochanek, M; Michels, G; Shimabukuro-Vornhagen, A; von Bergwelt-Baildon, M | 1 |
| Czock, D; de Groot, K; Fliser, D; Hafer, C; Haller, H; Hüsig-Linde, C; Keller, F; Kielstein, JT; Kuse, E; Langhoff, A; Schöpke, T; Swoboda, S | 1 |
1 review(s) available for moxifloxacin and Multiple Organ Failure
| Article | Year |
|---|---|
[Sepsis. Update 2012].
Topics: Anti-Bacterial Agents; Aza Compounds; Blood Volume; Central Venous Pressure; Drug Therapy, Combination; Empiricism; Fluid Therapy; Fluoroquinolones; Guideline Adherence; Humans; Moxifloxacin; Multiple Organ Failure; Protein C; Quinolines; Recombinant Proteins; Sepsis; Survival Analysis; Systemic Inflammatory Response Syndrome | 2012 |
1 trial(s) available for moxifloxacin and Multiple Organ Failure
| Article | Year |
|---|---|
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Meropenem; Middle Aged; Moxifloxacin; Multiple Organ Failure; Quinolines; Sepsis; Shock, Septic; Survival Analysis; Thienamycins; Treatment Outcome | 2012 |
3 other study(ies) available for moxifloxacin and Multiple Organ Failure
| Article | Year |
|---|---|
Moxifloxacin-induced multiple organ dysfunction possibly related to mutations in several genes involved in drug metabolism pathways.
Topics: Aged; Arylsulfotransferase; Aza Compounds; Fluoroquinolones; Genetic Predisposition to Disease; Humans; Male; Moxifloxacin; Multidrug Resistance-Associated Proteins; Multiple Organ Failure; Mutation; Quinolines | 2013 |
[A case of Legionella pneumonia with multiple organ failure].
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Legionella; Legionnaires' Disease; Male; Middle Aged; Moxifloxacin; Multiple Organ Failure; Pneumonia, Bacterial | 2016 |
Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Anuria; Aza Compounds; Critical Care; Critical Illness; Female; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Male; Metabolic Clearance Rate; Middle Aged; Moxifloxacin; Multiple Organ Failure; Ofloxacin; Quinolines; Renal Dialysis; Sepsis | 2006 |